ConMed Corporation (NASDAQ: CNMD) today announced that it intends to offer, subject to market conditions and other factors, $275 million aggregate principal amount of its convertible senior notes due 2024 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
January 23, 2019
· 7 min read